Henry Friesen
Corporate Officer/Principal chez University of Manitoba
Profil
Henry Friesen is a Professor-Emeritus at the University of Manitoba, where he has been employed since 2000.
He was the Founding Chairman of Genome Canada from 2000 to 2005 and the Chairman of the Gairdner Foundation from 2002 to 2009.
He has also served as a Director for Spectral Medical, Inc., YM BioSciences, Inc., Trillium Therapeutics ULC, Sanofi Pasteur Ltd., and Lombard Life Sciences.
From 1991 to 2000, he was the President of the Medical Research Council of Canada and the National Cancer Institute of Canada.
He was also the President of the Canadian Institutes of Health Research from 2000 to 2000 and the President of the Canadian Society For Clinical Investigation.
Friesen received his undergraduate degree from the University of Manitoba.
Postes actifs de Henry Friesen
| Sociétés | Poste | Début |
|---|---|---|
| University of Manitoba | Corporate Officer/Principal | 01/10/2000 |
Anciens postes connus de Henry Friesen
| Sociétés | Poste | Fin |
|---|---|---|
Lombard Life Sciences
 Lombard Life Sciences Investment ManagersFinance Lombard Life Sciences (Lombard Life Sciences) is a venture capital firm founded in 2002. The firm is headquartered in Winnipeg, Canada. | Corporate Officer/Principal | 01/01/2010 |
| Gairdner Foundation | Président | 01/01/2009 |
Genome Canada
 Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Président | 01/07/2005 |
| Medical Research Council of Canada | President | 01/01/2000 |
Canadian Institutes of Health Research
 Canadian Institutes of Health Research Miscellaneous Commercial ServicesCommercial Services The Canadian Institutes of Health Research is the federal health research financing organization in Canada. The non-profit company is based in Ottawa, Canada. The organization's main focus is to fund health research projects across the country. | Corporate Officer/Principal | 01/01/2000 |
Formation de Henry Friesen
| University of Manitoba | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SPECTRAL MEDICAL INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | Health Technology |
Sanofi Pasteur Ltd.
 Sanofi Pasteur Ltd. BiotechnologyHealth Technology Sanofi Pasteur Ltd. develops, manufactures, and markets vaccines and immunotherapeutic products. It offers vaccines for haemophilus influenza type B (Hib), diphtheria, pertussis, poliomyelitis, tetanus, hepatitis A, influenza, poliomyelitis, rabies, meningococcal disease, typhoid fever, and yellow fever, as well as oncology products for bladder cancers. The company was founded John Gerald FitzGerald in 1914 and is headquartered in Toronto, Canada. | Health Technology |
Lombard Life Sciences
Lombard Life Sciences Investment ManagersFinance Lombard Life Sciences (Lombard Life Sciences) is a venture capital firm founded in 2002. The firm is headquartered in Winnipeg, Canada. | Finance |
| Gairdner Foundation | |
| Medical Research Council of Canada | |
Canadian Institutes of Health Research
Canadian Institutes of Health Research Miscellaneous Commercial ServicesCommercial Services The Canadian Institutes of Health Research is the federal health research financing organization in Canada. The non-profit company is based in Ottawa, Canada. The organization's main focus is to fund health research projects across the country. | Commercial Services |
Genome Canada
Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Commercial Services |
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
| National Cancer Institute of Canada | |
| Canadian Society For Clinical Investigation |
